BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 29414639)

  • 21. Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.
    Pang C; Zheng Z; Shi L; Sheng Y; Wei H; Wang Z; Ji L
    Free Radic Biol Med; 2016 Feb; 91():236-46. PubMed ID: 26721592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis.
    Lv H; An B; Yu Q; Cao Y; Liu Y; Li S
    Int J Biol Macromol; 2020 Jul; 155():1092-1104. PubMed ID: 31712142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
    Lyu Z; Ji X; Chen G; An B
    Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
    Tang F; Fan K; Wang K; Bian C
    Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Li Z; Feng H; Wang Y; Shen B; Tian Y; Wu L; Zhang Q; Jin M; Liu G
    Int Immunopharmacol; 2019 Feb; 67():465-472. PubMed ID: 30597292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Panaxynol from
    Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
    Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
    Huang H; Zhang X; Li J
    J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats.
    Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC
    Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
    He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
    Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary luteolin attenuates chronic liver injury induced by mercuric chloride via the Nrf2/NF-κB/P53 signaling pathway in rats.
    Zhang H; Tan X; Yang D; Lu J; Liu B; Baiyun R; Zhang Z
    Oncotarget; 2017 Jun; 8(25):40982-40993. PubMed ID: 28498799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
    Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M
    Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
    Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
    Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
    Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
    Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells.
    Yang S; Kuang G; Zhang L; Wu S; Zhao Z; Wang B; Yin X; Gong X; Wan J
    Front Immunol; 2020; 11():285. PubMed ID: 32158448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanol extracts of Rhaponticum uniflorum (L.) DC inflorescence ameliorate LPS-mediated acute lung injury by alleviating inflammatory responses via the Nrf2/HO-1 signaling pathway.
    Zhen D; Liu C; Huang T; Fu D; Bai X; Ma Q; Jiang M; Gong G
    J Ethnopharmacol; 2022 Oct; 296():115497. PubMed ID: 35738472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoprotective effect of quercetin against LPS/d-GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways.
    Peng Z; Gong X; Yang Y; Huang L; Zhang Q; Zhang P; Wan R; Zhang B
    Int Immunopharmacol; 2017 Nov; 52():281-289. PubMed ID: 28963941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
    Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
    Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
    Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
    Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.